39647-97-7Relevant articles and documents
Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 1. (±)-(3-Pyridinylbicycloheptyl)alkanoic acids
Bhagwat,Gude,Cohen,Lee,Furness,Clarke
, p. 1790 - 1797 (1991)
The design, synthesis, and in vitro pharmacology of a new class of compounds exerting both thromboxane receptor antagonist and thromboxane synthase inhibtory activities is described. [(3-Pyridinyl)bicycloheptyl]alkanoic acid 9 and its analogues, designed